Surely, at the least it proves a lack of consistency at the highest echelons of the NHS Knowledge Management service. As on the one hand they do not renew the subscription to Clinical Evidence for the NLH, but decide to jump into bed with the Prodigy system and on the other hand the team behind Map of Medicine, which is “slowly” being cascaded across the country, have branded BMJ Clinical Evidence as the “Gold Standard”. So its good enough for MoM, but obviously not for the NLH!

 

Regards

 

David Law

Library & Information Services Manager

Royal Wolverhampton Hospitals NHS Trust

Tel 01902 695322

e-mail: [log in to unmask]

 

 

 


From: UK medical/ health care library community / information workers [mailto:[log in to unmask]]
Sent: 22 June 2007 13:37
To: [log in to unmask]
Subject: Re: BMJ Group press release: New partnership delivers ? gold standard' evidence at the point of care

 

So why has NHS in England not renewed sub. to Clinical Evidence?

 

Or have I missed something?

 

Brenda

 

 

Library and Knowledge Services Manager

Healthcare Library, Mailpoint 50

Winchester and Eastleigh Healthcare NHS Trust

Romsey Road

Winchester

Hampshire SO22 5DG

Tel: 01962 825709

-----Original Message-----
From: UK medical/ health care library community / information workers [mailto:[log in to unmask]]
Sent: 22 June 2007 11:58
To: [log in to unmask]
Subject: BMJ Group press release: New partnership delivers ? gold standard' evidence at the point of care

BMJ Group press release: New partnership delivers ‘gold standard' evidence at the point of care



The BMJ Group has teamed up with the Map of Medicine to supply an evidence surveillance service to underpin the Map of Medicine for clinicians across the NHS.

The Map of Medicine is a web-based tool that provides national and local ‘pathways’ of best practice for over 380 medical conditions. It presents the diagnostic and treatment information that clinicians need when they’re caring for patients in an intuitive, flow-chart format.

Under the partnership, the BMJ Group’s Knowledge team of clinical and scientific editors will provide a continuous evidence surveillance service for Map of Medicine pathways, based on identification and critical appraisal of emerging research and systematic reviews, new international guidelines, and drug safety alerts.

New evidence will be matched with existing pathways so that the Map of Medicine can be updated accordingly. This will ensure that clinicians can be confident that by following the pathways, they are practising in a manner that is consistent with the latest research evidence.

“With greater emphasis on patient safety and standards of care, the need for good quality evidence-based information to support care pathways and decision support tools is greater than ever,” says Dr David Tovey, Editorial Director at the BMJ Group. “This partnership is an important step towards improving patient care directly through evidence-based knowledge.”

Neil Ferguson from the Map of Medicine said: “The BMJ Group has been a leader in the field of evidence-based medicine since 1999 and is respected internationally for its integrity, independence, and high quality products. Their process for searching through, appraising and reviewing latest studies is second to none and we are delighted to have their expertise behind ‘the Map’. With their help, we look forward to delivering the highest quality evidence-based information to our users.”

Ends

Notes to Editors:
The Map of Medicine, in partnership with the NHS National Library for Health, is a knowledge management tool designed to:

The clinical knowledge in the Map of Medicine is visually presented in more than 380 patient ‘journeys’ starting from an initial patient visit. The content covers all major diagnostic areas including accident and emergency, internal medicine, surgery, paediatrics, obstetrics, gynaecology, oncology and palliative care.  

The BMJ Group is one of the world leaders in medical publishing. The Group publishes and distributes leading journals covering all major medical specialties and Clinical Evidence, the international source of the best available evidence for effective health care, freely available to over one million clinicians worldwide, and translated into 7 languages. In the UK Clinical Evidence is freely available to health professionals in Scotland and Wales, and via subscription in England.

Ends









----------------------------------------------------
Jane McHugh, Information Specialist
BMJ Knowledge, BMJ Group
BMA House, Tavistock Square, London WC1H 9JR
Tel: 020 7383 6384 Fax: 020 7383 6242

http://www.clinicalevidence.com
http://www.besttreatments.co.uk


**********************************************************************
This email and any files transmitted with it are confidential and
intended solely for the use of the individual or entity to whom they
are addressed. If you have received this email in error please notify
[log in to unmask]

**********************************************************************

_______________________________________________________________________

This email and any attachments are confidential and intended solely for the addressee. They may not be disclosed to, used by or copied in any way by anyone other than the intended recipient. If you have received this email in error please notify [log in to unmask] and delete the email transmission immediately.

Any views expressed in this email are those of the individual and may not represent those of the BMJ Publishing Group Ltd.

Computer viruses can be transmitted by email. The recipient should check this email and any attachments for presence of viruses.The BMJ Publishing Group Ltd accepts no liability for damage caused by any virus transmitted by this email. Emails sent or received by the BMJ Publishing Group are monitored.

BMJ Publishing Group Limited
A private limited company, registered in England and Wales under registered number 03102371
Registered office: BMA House, Tavistock Square, London WC1H 9JR, UK. http://bmjgroup.bmj.com
_______________________________________________________________________

***************************************************************************

This e-mail is confidential and privileged. If you are not the intended recipient please accept our apologies; please do not disclose, copy or distribute information in this e-mail or take any action in reliance on its

contents: to do so is strictly prohibited and may be unlawful. Please inform us that this message has gone astray before deleting it. Thank you for your co-operation.

This footnote also confirms that this email message has been swept by MIMEsweeper for the presence of computer viruses.

***************************************************************************

**************************************************************************
DISCLAIMER: This e-mail and any files attached may be confidential.
It is intended for the addressee(s) only. If you are not the
recipient, any reading, printing, disclosure, copying or any
other action taken in respect of this e-mail is prohibited and
may be unlawful. If you are not the intended recipient, please
notify the sender immediately by using the reply function and then
permanently delete what you have received.

The views expressed in this email are not necessarily the views
of the Royal Wolverhampton Hospitals NHS Trust.

This e-mail has been checked for viruses but this does not
guarantee that it is virus free.
**************************************************************************